Public-Private Partnerships in the Wake of COVID-19
As the outbreak of COVID-19, a disease caused by a novel strain of coronavirus, evolves around the world, the public and private sectors are diligently working together to find solutions.
New Report: Clinical Research Drives Health Innovation
Southeast Asia is home to nearly 9 percent of the world’s population and one of the fastest growing economic regions in the world. Thanks to treatment breakthroughs and wider health care access, people across the region are living longer than ever before. There is tremendous opportunity to build on this foundation through additional investment in early stage clinical research and pro-innovation policy reforms that continue to improve the health for those living in Southeast Asia.
Healthy Innovation Statement on COVID-19
Our thoughts are with those affected by the outbreak of COVID-19, the novel strain of the coronavirus, both here in Southeast Asia and around the globe.
The Regulatory Standards that Facilitate Quality Health Care Outcomes
Challenges in the global regulatory environment coupled with increased demand for patient access to new treatments have put pressure on authorities in Asia to strengthen regulatory processes. As Asia looks to further innovation and ensure new medicines can be made available to patients, strong regulatory systems and intellectual property protections will be critical.